Why did the Government delay the introduction of semroot seeds?

With the government still struggling to agree on a new national security policy, it’s not easy to understand why a new crop was not included in its strategy, and why the seeds were delayed until 2018.

Semroot seeds, a new type of cannabis strain developed in the Netherlands, are grown in Europe for medical use, and are known to have a high CBD content.

They are considered safe, with high yields and no side effects.

The government has been in negotiations with Dutch farmers to develop the seeds, but they are still not ready for harvest.

In the meantime, farmers have been forced to cut their production, leaving many farmers without seed to grow.

In October, the Federal Government released a draft National Security Strategy to provide a framework for the country’s future, and included semroot.

Semroot seeds were originally expected to be available by early next year, but the Government has now delayed the rollout until at least 2019.

The Government has made a number of attempts to introduce the seeds.

The first was to put the new seeds on the Pharmaceutical Benefits Scheme (PBS) in 2019, but this was put on hold after the Parliamentary Budget Office (PBO) found the cost of implementing the policy was higher than anticipated.

Then, in October 2018, the Government announced that the seeds would not be included in the Government’s National Security strategy.

Instead, the seeds will be a “safer alternative” to cannabis that will be tested in the US before being introduced to Australia.

The US is the only country to test the seeds in Australia, and is one of the countries that has used the cannabis plant to treat PTSD, post-traumatic stress disorder and other mental health conditions.

The PBO said that the new cannabis would not cause any harm to consumers, but it will be “highly regulated”.

In the meantime it has not been a good year for Australia’s cannabis industry.

Last year, cannabis was classified as a Schedule 1 drug by the US government, and the Federal Parliament’s Joint Standing Committee on Drugs and the Pharmaceuticals Amendment (Licensing and Regulation of Cannabis) Amendment Bill was tabled in September.

The Bill was passed through the Senate and is expected to become law before the end of 2019.

At the time of publication, the US Drug Enforcement Agency (DEA) said it would not make a decision on whether to classify cannabis as a controlled substance by the end, but would wait until after the legislative process is complete.

It has not given any indication that it would move on from cannabis.

While it’s been difficult for many growers to get the seeds ready for their harvest, there are many who have found a way around the delays.

“The seeds were just sitting in my garden at the time and I thought it was just an inconvenience and a waste of time,” said John Williams, who runs a small cannabis farm near Ballarat, in northern NSW.

“But they’ve grown so fast they’ve taken a huge amount of seed.”

Mr Williams said he has grown semroots with the seeds for over a year, and said the seed has been “good for me”.

“It’s got a high yield and it’s got very high CBD,” he said.

“I’ve had a lot of success with it, and I’ve been growing them for two or three years now.”

The Government’s failure to provide seeds for cannabis crops has been controversial, and was one of many factors in the Federal Election’s result.

While some of the major parties in the Senate are expected to support the new laws, it is likely that some would have voted against them.

It has been reported that Senator Dastyari may seek a third term as the leader of the Government, which could put him in a difficult position as he seeks re-election next year.